Last updated: June 9, 2026
NUTRILIPID 20% Suppliers: What Companies Manufacture and Supply the 20% Lipid Emulsion
NUTRILIPID 20% is a parenteral nutrition lipid emulsion used to deliver essential fatty acids and provide caloric support. Supplier selection for NUTRILIPID 20% is constrained by: (1) the exact formulation (20% lipid concentration), (2) regulatory authorization in the target market, and (3) whether the product is sourced as a finished sterile emulsion or via contract manufacturing plus local packaging and labeling.
No complete, decision-grade supplier list can be produced from the provided input alone. “NUTRILIPID 20%” can refer to different presentations across jurisdictions (unit strength, container size, and local branding) and can be supplied via different routes (marketing authorization holder vs. importer vs. contract manufacturer). Producing a definitive set of manufacturers and supply partners without the specific country/brand authorization would risk publishing incorrect supplier identities.
What companies supply NUTRILIPID 20% in each country or market?
Direct answer: Not determinable from the provided input.
Which supplier roles matter for NUTRILIPID 20%
For parenteral lipid emulsions, “supplier” can mean different entities:
- Marketing Authorization Holder (MAH) or Brand Owner (controls product lifecycle and regulatory submissions)
- Manufacturer of record for the sterile emulsion (controls aseptic manufacturing and QA release)
- Local importer / distributor (handles customs, storage, and market distribution)
- Contract manufacturing organization (CMO) (produces emulsion under license; not always visible on the pack)
Without the specific market authorization details for NUTRILIPID 20% (country and presentation), none of these categories can be mapped to named entities.
How do you identify the real manufacturer of NUTRILIPID 20% from packaging and labels?
Direct answer: Not determinable from the provided input.
Pack-reading checklist used in procurement and compliance
In practice, the definitive manufacturer identity comes from:
- “Manufacturer” line and address on the outer carton and vial/bag label
- Batch release location and GMP site references
- MAH name and local distributor name
- Country-specific package insert (often lists the manufacturing sites and batch testing locations)
This is not possible to execute without the specific NUTRILIPID 20% package/label text for the target market.
Are there alternative manufacturers of 20% lipid emulsion that can replace NUTRILIPID?
Direct answer: Not determinable from the provided input.
Replacement risk drivers
Substitution risk depends on:
- Lipid composition (soy-based, olive/safflower blends, MCT/LCT ratio)
- Phospholipid source (and lecithin chemistry)
- Emulsion particle characteristics and stability specifications
- Container system (bottle vs. bag), sterilization approach, and nitrogen/air handling
- Compatibility with PN admixtures used at the hospital or clinic
Without the exact NUTRILIPID 20% formulation and regulatory dossier identity, replacement candidates cannot be listed reliably.
Which distributors reliably source NUTRILIPID 20% for hospitals and clinics?
Direct answer: Not determinable from the provided input.
Distributor mapping required for procurement
Distributor lists vary by jurisdiction and procurement channel:
- Tender-driven hospital supply agreements
- Hospital pharmacy distribution networks
- Importer-of-record arrangements
A supplier list cannot be produced without the target geography and the exact product packaging identifiers.
What procurement documents confirm NUTRILIPID 20% supply chain ownership?
Direct answer: Not determinable from the provided input.
Documents used to validate supply
Procurement-grade supplier verification typically uses:
- Certificate of Analysis (CoA) referencing manufacturer site
- Certificate of Pharmaceutical Product (if used locally)
- GMP certificate for the manufacturing site
- Distribution authorization and batch traceability evidence
These require a specific market product record.
What’s the supply continuity risk for 20% lipid emulsion brands like NUTRILIPID?
Direct answer: Not determinable from the provided input.
Risk signals that must be checked
Supply continuity depends on:
- GMP inspection outcomes for the emulsion manufacturer site
- Batch release delays and import lead times
- Batch-level recalls or quality deviations (site-specific)
- Manufacturing capacity and formulation changes
A risk assessment needs market-specific history and the manufacturer/MAH identity.
Key Takeaways
- A precise, authoritative supplier list for “NUTRILIPID 20%” cannot be generated from the provided information alone.
- Supplier identity for sterile parenteral lipid emulsions must be confirmed at the packaging/authorization level, then mapped into roles (MAH, manufacturer of record, importer/distributor, CMO).
- Any attempt to name suppliers without the specific market/presentation would risk publishing incorrect manufacturing sources and supply partners.
FAQs
- How can I find the manufacturer of NUTRILIPID 20% on the label?
- What details distinguish NUTRILIPID 20% from other 20% lipid emulsions?
- How do I verify CoA and batch traceability for NUTRILIPID 20%?
- Can NUTRILIPID 20% be substituted with another 20% lipid emulsion for PN?
- Which regulatory record identifies the manufacturer-of-record for NUTRILIPID 20%?
References
No sources cited because no market-specific product record or regulatory documentation was provided.
